7,245
Views
41
CrossRef citations to date
0
Altmetric
Coronaviruses

SARS-CoV-2 reinfection and COVID-19 severity

, , , , , , , , & show all
Pages 894-901 | Received 31 Jan 2022, Accepted 07 Mar 2022, Published online: 21 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pasquale Pagliano, Carmine Sellitto, Tiziana Ascione, Giuliana Scarpati, Veronica Folliero, Ornella Piazza, Gianluigi Franci, Amelia Filippelli & Valeria Conti. (2022) The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19). Expert Opinion on Drug Discovery 17:12, pages 1299-1311.
Read now

Articles from other publishers (40)

Lea Schuh, Peter V. Markov, Vladimir M. Veliov & Nikolaos I. Stilianakis. (2024) A mathematical model for the within-host (re)infection dynamics of SARS-CoV-2. Mathematical Biosciences 371, pages 109178.
Crossref
Ling Zhang, Yijin Wu, Shu Jing, Xin Liu, Tianrui Ren, Xiaoyang Liu, Zhenwei Dai, Jiaqi Fu, Xu Chen, Weijun Xiao, Yiman Huang, Hao Wang, Wenjun Wang, Xiaofen Gu, Li Ma, Shaokai Zhang, Yanqin Yu, Li Li, Xiaoyou Su & Youlin Qiao. (2024) The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: A multicenter cross-sectional study. American Journal of Infection Control 52:5, pages 525-532.
Crossref
Xiaoju Ma, Zheng Wang, Youpeng Chen & Zhanjie Li. (2024) The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study. BMC Infectious Diseases 24:1.
Crossref
Ying Xie, Ishfaq Ahmad, ThankGod I. S. Ikpe, Elza F. Sofia & Hiromi Seno. (2024) What Influence Could the Acceptance of Visitors Cause on the Epidemic Dynamics of a Reinfectious Disease?: A Mathematical Model. Acta Biotheoretica 72:1.
Crossref
Jingwei Yue, Jin Cao, Lin Liu, Li Yin & Mingyue Li. (2024) Clinical characteristics of 4,520 paediatric patients infected with the SARS-CoV-2 omicron variant, in Xi'an, China. Frontiers in Pediatrics 12.
Crossref
Mengyan Zhang, Lei Cao, Luqian Zhang, Xinxin Li, Sa Chen & Yi Zhang. (2024) SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023. BMC Public Health 24:1.
Crossref
Håkon Bøås, Margrethe Larsdatter Storm, German Tapia, Anja Bråthen Kristoffersen, Astrid Louise Løvlie, Ketil Størdal, Trude Marie Lyngstad, Karoline Bragstad, Olav Hungnes & Lamprini Veneti. (2024) Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022. BMC Public Health 24:1.
Crossref
Jia-Hui Pang, Chang-Fu Guo, Peng-Liang Hao, Sheng-Li Meng, Jing Guo, Dou Zhang, Ya-Qi Ji & Ping-Gang Ming. (2024) Evaluation of the Robustness Verification of Downstream Production Process for Inactivated SARS-CoV-2 Vaccine and Different Chromatography Medium Purification Effects. Vaccines 12:1, pages 56.
Crossref
Boyeong Ryu, Eunjeong Shin, Dong Hwi Kim, HyunJu Lee, So Young Choi, Seong-Sun Kim, Il-Hwan Kim, Eun-Jin Kim, Sangwon Lee, Jaehyun Jeon, Donghyok Kwon & Sungil Cho. (2024) Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to the emerging variant: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations. BMC Infectious Diseases 24:1.
Crossref
Walter Gómez-Gonzales, Luis A. Chihuantito-Abal, Carlos Gamarra-Bustillos, Julia Morón-Valenzuela, Jenny Zavaleta-Oliver, Maria Gomez-Livias, Lidia Vargas-Pancorbo, María E. Auqui-Canchari & Henry Mejía-Zambrano. (2023) Risk Factors Contributing to Reinfection by SARS-CoV-2: A Systematic Review. Advances in Respiratory Medicine 91:6, pages 560-570.
Crossref
Manish Dhawan, AbdulRahman A. Saied & Manish Sharma. (2023) Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?. Health Sciences Review 9, pages 100127.
Crossref
Xiao Ge, Huizi Zhou, Fangyuan Shen, Guimao Yang, Yubo Zhang, Xiaoyu Zhang & Heng Li. (2023) SARS-CoV-2 subgenomic RNA: formation process and rapid molecular diagnostic methods. Clinical Chemistry and Laboratory Medicine (CCLM) 0:0.
Crossref
Nabihah Farhana Ismail, Ahmed Ehsanur Rahman, Durga Kulkarni, Fuyu Zhu, Xin Wang, Graciela del Carmen Morales, Amit Srivastava, Kristen E Allen, Julia Spinardi, Moe H Kyaw & Harish Nair. (2023) Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis. Journal of Global Health 13.
Crossref
Aytaj Allahverdiyeva, Ali Ağaçfidan, Lerzan Dogan, Mustafa Önel, Hayriye Kırkoyun Uysal, Alpay Medetalibeyoğlu, Naci Şenkal, Elvin Alaskarov & Sevim Meşe. (2023) Evaluation of SARS-CoV-2-Positive Patients with Suspected Reinfection. Viruses 15:11, pages 2222.
Crossref
Shan Zhang, Qing Liu, Fan Yang, Jiawei Zhang, Yaqun Fu, Zheng Zhu, Jing Guo, Xiaoguang Li & Li Yang. (2023) Associations between COVID-19 infection experiences and mental health problems among Chinese adults: A large cross-section study. Journal of Affective Disorders 340, pages 719-727.
Crossref
Yin Wang, Jie Liang, Huimin Yang, Liguo Zhu, Jianli Hu, Lishun Xiao, Yao Huang, Yuying Dong, Cheng Wu, Jun Zhang & Xin Zhou. (2023) Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province. Frontiers in Public Health 11.
Crossref
Ana Paula Moreira Franco-Luiz, Nubia Monteiro Gonçalves Soares Fernandes, Thais Bárbara de Souza Silva, Wilma Patrícia de Oliveira Santos Bernardes, Mateus Rodrigues Westin, Thais Garcia Santos, Gabriel da Rocha Fernandes, Taynãna César Simões, Eduardo Fernandes E. Silva, Sandra Grossi Gava, Breno Magalhães Alves, Mariana de Carvalho Melo, Rosiane A. da Silva-Pereira, Pedro Augusto Alves & Cristina Toscano Fonseca. (2023) Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics. Frontiers in Immunology 14.
Crossref
Claudio Acuña-Castillo, Carlos Barrera-Avalos, Vivienne C. Bachelet, Luis A. Milla, Ailén Inostroza-Molina, Mabel Vidal, Roberto Luraschi, Eva Vallejos-Vidal, Andrea Mella-Torres, Daniel Valdés, Felipe E. Reyes-López, Mónica Imarai, Patricio Rojas & Ana María Sandino. (2023) An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile. Frontiers in Public Health 11.
Crossref
Yiman Huang, Ling Zhang, Jiaqi Fu, Yijin Wu, Hao Wang, Weijun Xiao, You Xin, Zhenwei Dai, Mingyu Si, Xu Chen, Mengmeng Jia, Zhiwei Leng, Dan Cui & Xiaoyou Su. (2023) COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study. JMIR Public Health and Surveillance 9, pages e42958.
Crossref
Carlos Rescalvo-Casas, Ramón Pérez-Tanoira, Rocío Fernández Villegas, Marcos Hernando-Gozalo, Laura Seijas-Pereda, Felipe Pérez-García, Helena Moza Moríñigo, Peña Gómez-Herruz, Teresa Arroyo, Rosa González, Cristina Verdú Expósito, Lourdes Lledó García, Juan Romanyk Cabrera & Juan Cuadros-González. (2023) Clinical Evolution and Risk Factors in Patients Infected during the First Wave of COVID-19: A Two-Year Longitudinal Study. Tropical Medicine and Infectious Disease 8:7, pages 340.
Crossref
Laith Ebraham, Chuan Xu, Annie Wang, Cyril Hernandez, Nicholas Siclari, Divino Rajah, Lewins Walter, Salvatore A. E. Marras, Sanjay Tyagi, Daniel H. Fine, Carlo Amorin Daep & Theresa L. Chang. (2023) Oral Epithelial Cells Expressing Low or Undetectable Levels of Human Angiotensin-Converting Enzyme 2 Are Susceptible to SARS-CoV-2 Virus Infection In Vitro. Pathogens 12:6, pages 843.
Crossref
성주 최, 충민 박, 한울 박, 연화 정, 명재 황 & 태종 손. (2023) 경북권(대구·경북) 코로나바이러스감염증-19 재감염 추정 현황 및 위험요인 분석. Public Health Weekly Report 16:23, pages 726-740.
Crossref
Wenhai Yu, Junbin Wang, Yun Yang, Cong Tang, Chengyun Yang, Bai Li, Haixuan Wang, Yanan Zhou, Qing Huang, Hao Yang, Daoju Wu, Zhiwu Luo, Jiahong Gao, Dexuan Kuang, Haiting Long, Xiaozhong Peng, Zhongping Xie & Shuaiyao Lu. (2023) SARS‐CoV‐2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage. Journal of Medical Virology 95:6.
Crossref
Nhu Ngoc Nguyen, Y Ngoc Nguyen, Van Thuan Hoang, Matthieu Million & Philippe Gautret. (2023) SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis. Viruses 15:4, pages 967.
Crossref
José Antonio Montes-González, Christian Arturo Zaragoza-Jiménez, Neftali Eduardo Antonio-Villa, Carlos A. Fermín-Martínez, Daniel Ramírez-García, Arsenio Vargas-Vázquez, Rosaura Idania Gutiérrez-Vargas, Gabriel García-Rodríguez, Hugo López-Gatell, Sergio Iván Valdés-Ferrer & Omar Yaxmehen Bello-Chavolla. (2023) Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico. Frontiers in Public Health 11.
Crossref
Heui Man KimEun Ju LeeSang Won OYong Jun ChoiHyeokjin LeeSae Jin OhJeong-Min KimAe Kyung ParkJeong-Ah KimChae young LeeJong Mu KimHanul ParkYoung Joon ParkJeong-Hee YuEun-Young KimHwa-Pyeong KoEun-Jin Kim. (2023) A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection. Viral Immunology 36:3, pages 203-208.
Crossref
Mingtao Liu, Hui Gan, Zhiman Liang, Li Liu, Qiwen Liu, Yiyin Mai, Huihuang Chen, Baoying Lei, Shangwei Yu, Huihui Chen, Peiyan Zheng & Baoqing Sun. (2023) Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies. Frontiers in Microbiology 14.
Crossref
Xóchitl Trujillo, Oliver Mendoza-Cano, Mónica Ríos-Silva, Miguel Huerta, José Guzmán-Esquivel, Verónica Benites-Godínez, Agustin Lugo-Radillo, Jaime Alberto Bricio-Barrios, Martha I. Cárdenas-Rojas, Eder Fernando Ríos-Bracamontes, Vannya Marisol Ortega-Macías, Valeria Ruiz-Montes de Oca & Efrén Murillo-Zamora. (2023) Predictors of Recurrent Laboratory-Confirmed Symptomatic SARS-CoV-2 Infections in a Cohort of Healthcare Workers. Vaccines 11:3, pages 626.
Crossref
Rashmi Rana, Ravi Kant, Tanya Kumra, Sneha Gupta, Devinder Singh Rana & Nirmal Kumar Ganguly. (2023) An update on SARS-CoV-2 immunization and future directions. Frontiers in Pharmacology 14.
Crossref
Tianyu Lu, Qiuhong Man, Xueying Yu, Shuai Xia, Lu Lu, Shibo Jiang & Lize Xiong. (2023) Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infection. Frontiers in Immunology 14.
Crossref
Wei He, Xinze Shi, Haifei Guan, Yuntong Zou, Shengkun Zhang, Zhiwen Jiang & Shuo Su. (2023) Identification of a novel linear B-cell epitope in porcine deltacoronavirus nucleocapsid protein. Applied Microbiology and Biotechnology 107:2-3, pages 651-661.
Crossref
Levente Zsichla & Viktor Müller. (2023) Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. Viruses 15:1, pages 175.
Crossref
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, Kuldeep Dhama & Chiranjib Chakraborty. (2023) A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies. Viruses 15:1, pages 167.
Crossref
Chuanmeng Zhang, Ting Guo, Lei Zhang, Aiqin Gu, Jun Ye, Mei Lin, Ming Chu, Fengcai Zhu & Li Zhu. (2023) The Infection of Healthcare Workers and the Reinfection of Patients by Omicron Variant — Jiangsu Province, China, December 2022 to January 2023. China CDC Weekly 5:18, pages 402-406.
Crossref
Suhyeon Lim, Monica Zhang & Theresa L. Chang. (2022) ACE2-Independent Alternative Receptors for SARS-CoV-2. Viruses 14:11, pages 2535.
Crossref
Maria Francesca Piazza, Daniela Amicizia, Francesca Marchini, Matteo Astengo, Federico Grammatico, Alberto Battaglini, Camilla Sticchi, Chiara Paganino, Rosa Lavieri, Giovanni Battista Andreoli, Andrea Orsi, Giancarlo Icardi & Filippo Ansaldi. (2022) Who Is at Higher Risk of SARS-CoV-2 Reinfection? Results from a Northern Region of Italy. Vaccines 10:11, pages 1885.
Crossref
Chiara Agrati, Rita Carsetti, Veronica Bordoni, Alessandra Sacchi, Concetta Quintarelli, Franco Locatelli, Giuseppe Ippolito & Maria R. Capobianchi. (2022) The immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic . Immunology 167:3, pages 287-302.
Crossref
Su Jin Lee, Yu-Jin Kim & Dae-Gyun Ahn. (2022) Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2. Journal of Microbiology and Biotechnology 32:9, pages 1073-1085.
Crossref
Nhu Ngoc Nguyen, Linda Houhamdi, Van Thuan Hoang, Didier Stoupan, Pierre-Edouard Fournier, Didier Raoult, Philippe Colson & Philippe Gautret. (2022) High rate of reinfection with the SARS-CoV-2 Omicron variant. Journal of Infection 85:2, pages 174-211.
Crossref
Phuc H. Phan, Dung T. Nguyen, Nam H. Dao, Ha T. T. Nguyen, An V. Vu, Son T. Hoang, Lam V. Nguyen, Tung V. Cao & Dien M. Tran. (2022) Case Report: Successful Treatment of a Child With COVID-19 Reinfection-Induced Fulminant Myocarditis by Cytokine-Adsorbing oXiris® Hemofilter Continuous Veno-Venous Hemofiltration and Extracorporeal Membrane Oxygenation. Frontiers in Pediatrics 10.
Crossref